4.2 Article

Gene Expression Suggests Spontaneously Hypertensive Rats May Have Altered Metabolism and Reduced Hypoxic Tolerance

Journal

CURRENT NEUROVASCULAR RESEARCH
Volume 9, Issue 1, Pages 10-19

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156720212799297074

Keywords

cDNA microarrays; energy metabolism; hypoxia; small vessel disease; SHR; WKY

Ask authors/readers for more resources

Cerebral small vessel disease (SVD) is an important cause of stroke, cognitive decline and vascular dementia (VaD). It is associated with diffuse white matter abnormalities and small deep cerebral ischemic infarcts. The molecular mechanisms involved in the development and progression of SVD are unclear. As hypertension is a major risk factor for developing SVD, Spontaneously Hypertensive Rats (SHR) are considered an appropriate experimental model for SVD. Prior work suggested an imbalance between the number of blood microvessels and astrocytes at the level of the neurovascular unit in 2-month-old SHR, leading to neuronal hypoxia in the brain of 9-month-old animals. To identify genes and pathways involved in the development of SVD, we compared the gene expression profile in the cortex of 2 and 9-month-old of SHR with age-matched normotensive Wistar Kyoto (WKY) rats using microarray-based technology. The results revealed significant differences in expression of genes involved in energy and lipid metabolisms, mitochondrial functions, oxidative stress and ischemic responses between both groups. These results strongly suggest that SHR suffer from chronic hypoxia, and therefore are unable to tolerate ischemia-like conditions, and are more vulnerable to high-energy needs than WKY. This molecular analysis gives new insights about pathways accounting for the development of SVD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study

Fine Dietrich, Alexandros A. Polymeris, Melina Verbeek, Stefan T. Engelter, Kurt E. Hersberger, Sabine Schaedelin, Isabelle Arnet, Philippe A. Lyrer

Summary: The study suggests that a major disruption of social life (i.e., the imposed COVID-19 lockdown) is unlikely to significantly affect the medication intake behavior of patients with high pre-established adherence, but might have an impact on patients with previously suboptimal adherence.

JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation

Alexandros A. Polymeris, Kosmas Macha, Maurizio Paciaroni, Duncan Wilson, Masatoshi Koga, Manuel Cappellari, Sabine Schaedelin, Annaelle Zietz, Nils Peters, David J. Seiffge, David Haupenthal, Luise Gassmann, Gian Marco De Marchis, Ruihao Wang, Henrik Gensicke, Svenja Stoll, Sebastian Thilemann, Nikolaos S. Avramiotis, Bruno Bonetti, Georgios Tsivgoulis, Gareth Ambler, Andrea Alberti, Sohei Yoshimura, Martin M. Brown, Masayuki Shiozawa, Gregory Y. H. Lip, Michele Venti, Monica Acciarresi, Kanta Tanaka, Maria Giulia Mosconi, Masahito Takagi, Rolf H. Jager, Keith Muir, Manabu Inoue, Stefan Schwab, Leo H. Bonati, Philippe A. Lyrer, Kazunori Toyoda, Valeria Caso, David J. Werring, Bernd Kallmuenzer, Stefan T. Engelter

Summary: This study investigated the safety and effectiveness of DOAC versus VKA in patients aged >= 85 years with atrial fibrillation after recent stroke. The results showed that there was no significant difference in the composite outcome risk between DOAC and VKA in the oldest old patients.

ANNALS OF NEUROLOGY (2022)

Article Clinical Neurology

Association of the COVID-19 outbreak with acute stroke care in Switzerland

Gian Marco De Marchis, Patrick R. Wright, Patrik Michel, Davide Strambo, Emmanuel Carrera, Elisabeth Dirren, Andreas R. Luft, Susanne Wegener, Carlo W. Cereda, Georg Kagi, Jochen Vehoff, Henrik Gensicke, Philippe Lyrer, Krassen Nedeltchev, Timo Khales, Manuel Bolognese, Stephan Salmen, Rolf Sturzenegger, Christophe Bonvin, Christian Berger, Ludwig Schelosky, Marie-Luise Mono, Biljana Rodic, Andrea von Reding, Guido Schwegler, Alexander A. Tarnutzer, Friedrich Medlin, Andrea M. Humm, Nils Peters, Morin Beyeler, Lilian Kriemler, David Bervini, Javier Fandino, Lars G. Hemkens, Pasquale Mordasini, Marcel Arnold, Urs Fischer, Leo H. Bonati

Summary: This study aimed to assess the impact of the COVID-19 outbreak on acute stroke care in Switzerland. The results showed a significant decrease in hospital admissions and clinical severity of acute cerebrovascular events during the lockdown period, while the delivery and quality of acute stroke care remained unaffected.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis

Gian Marco De Marchis, David J. Seiffge, Sabine Schaedelin, Duncan Wilson, Valeria Caso, Monica Acciarresi, Georgios Tsivgoulis, Masatoshi Koga, Sohei Yoshimura, Kazunori Toyoda, Manuel Cappellari, Bruno Bonetti, Kosmas Macha, Bernd Kallmuenzer, Carlo W. Cereda, Philippe Lyrer, Leo H. Bonati, Maurizio Paciaroni, Stefan T. Engelter, David J. Werring

Summary: This study compared the optimal timing of starting direct oral anticoagulants (DOACs) after acute ischemic stroke (AIS) related to atrial fibrillation (AF) and found no significant difference in the risk of recurrent AIS and intracranial hemorrhage between early versus late DOAC-start groups. The sevenfold higher risk of recurrent AIS than intracranial hemorrhage suggests that an early DOAC-start might be reasonable, supporting enrollment into randomized trials comparing an early versus late DOAC-start.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Clinical Neurology

Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial

Zhe Kang Law, Jason P. Appleton, Polly Scutt, Ian Roberts, Rustam Al-Shahi Salman, Timothy J. England, David J. Werring, Thompson Robinson, Kailash Krishnan, Robert A. Dineen, Ann Charlotte Laska, Philippe A. Lyrer, Juan Jose Egea-Guerrero, Michal Karlinski, Hanne Christensen, Christine Roffe, Daniel Bereczki, Serefnur Ozturk, Jegan Thanabalan, Ronan Collins, Maia Beridze, Alfonso Ciccone, Lelia Duley, Angela Shone, Philip M. Bath, Nikola Sprigg

Summary: This study explored the association between different consent pathways and time to enrollment in acute stroke trials. The findings suggest that using an initial brief consent may lead to shorter time to enrollment while maintaining good participant retention.

STROKE (2022)

Article Cardiac & Cardiovascular Systems

Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage

Fabian Schaub, Alexandros A. Polymeris, Sabine Schaedelin, Lisa Hert, Louisa Meya, Sebastian Thilemann, Christopher Traenka, Benjamin Wagner, David Seiffge, Henrik Gensicke, Gian Marco De Marchis, Leo Bonati, Stefan T. Engelter, Nils Peters, Philippe Lyrer

Summary: The study found that AIS was more common than ICH in patients receiving oral anticoagulant treatment. Atherosclerosis and prior AIS/TIA were major risk factors for AIS/TIA, while small vessel disease markers and prior ICH were stronger determinants for ICH.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Clinical Neurology

Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation

Alexandros A. Polymeris, Thomas R. Meinel, Hannah Oehler, Kyra Hoelscher, Annaelle Zietz, Jan F. Scheitz, Christian H. Nolte, Christoph Stretz, Shadi Yaghi, Svenja Stoll, Ruihao Wang, Karl Georg Haeusler, Simon Hellwig, Markus G. Klammer, Simon Litmeier, Christopher R. Leon Guerrero, Iman Moeini-Naghani, Patrik Michel, Davide Strambo, Alexander Salerno, Giovanni Bianco, Carlo Cereda, Timo Uphaus, Klaus Groeschel, Mira Katan, Susanne Wegener, Nils Peters, Stefan T. Engelter, Philippe A. Lyrer, Leo H. Bonati, Lorenz Grunder, Peter Arthur Ringleb, Urs Fischer, Bernd Kallmuenzer, Jan C. Purrucker, David J. Seiffge

Summary: This study investigated the causes, preventive strategies, and outcomes of stroke in atrial fibrillation patients despite anticoagulation. The results showed that stroke had diverse causes, and some patients experienced cardioembolism despite sufficient anticoagulation. Treatment with DOAC was associated with better outcomes compared to VKA, while adding antiplatelets was linked to worse outcomes in high-risk patients. These findings suggest the need for individualized and novel preventive strategies.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Clinical Neurology

Endovascular Treatment for Acute Ischemic Stroke With or Without General Anesthesia: A Matched Comparison

Benjamin Wagner, Johannes Lorscheider, Andrea Wiencierz, Kristine Blackham, Marios Psychogios, Daniel Bolliger, Gian Marco De Marchis, Stefan T. Engelter, Philippe Lyrer, Patrick R. Wright, Urs Fischer, Pasquale Mordasini, Stefania Nannoni, Francesco Puccinelli, Timo Kahles, Giovanni Bianco, Emmanuel Carrera, Andreas R. Luft, Carlo W. Cereda, Georg Kagi, Johannes Weber, Krassen Nedeltchev, Patrik Michel, Jan Gralla, Marcel Arnold, Leo H. Bonati

Summary: This large study found that patients with anterior circulation stroke treated with general anesthesia during endovascular treatment had worse functional outcomes compared to those treated without general anesthesia. This finding appears to be independent of patient characteristic differences between the groups.

STROKE (2022)

Article Multidisciplinary Sciences

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program

Lea Beier, Shihai Lu, Lionel Riou Franca, Sabrina Marler, Gregory Y. H. Lip, Menno Huisman, Christine Teutsch, Jonathan L. Halperin, Kristina Zint, Hans-Christoph Diener, Laurie Baker, Chang-Sheng Ma, Miney Paquette, Dorothee B. Bartels, Sergio J. Dubner, Philippe Lyrer, Jochen Senges, Kenneth J. Rothman

Summary: The results of the third phase of the GLORIA-AF registry program show that OACs have become the standard treatment option for newly diagnosed AF patients, with most patients being prescribed a NOAC. However, there is still a significant proportion of patients who remain undertreated in certain regions.

PLOS ONE (2022)

Article Clinical Neurology

Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration

Valerian L. Altersberger, Norman Rusche, Nicolas Martinez-Majander, Christian Hametner, Jan F. Scheitz, Hilde Henon, Maria Luisa Dell'Acqua, Davide Strambo, Jeffrey Stolp, Mirjam R. Heldner, Ilaria Grisendi, Dejana R. Jovanovic, Yannick Bejot, Alessandro Pezzini, Ronen R. Leker, Georg Kagi, Susanne Wegener, Carlo W. Cereda, Erik Lindgren, George Ntaios, Ines Piot, Alexandros A. Polymeris, Philippe A. Lyrer, Silja Raty, Gerli Sibolt, Marjaana Tiainen, Miriam Heyse, Hebun Erdur, Olfa Kaaouana, Visnja Padjen, Marialuisa Zedde, Marcel Arnold, Paul J. Nederkoorn, Patrik Michel, Guido Bigliardi, Andrea Zini, Charlotte Cordonnier, Christian H. Nolte, Peter A. Ringleb, Sami Curtze, Stefan T. Engelter, Henrik Gensicke

Summary: Based on data from a large registry, this study found that the safety of intravenous thrombolysis in very elderly patients with acute ischemic stroke is similar to that in younger patients. However, the probability of death and poor functional outcome was higher in the very elderly group.

STROKE (2022)

Article Clinical Neurology

Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry

Benjamin Wagner, Lisa Hert, Alexandros A. Polymeris, Sabine Schaedelin, Johanna M. Lieb, David J. Seiffge, Christopher Traenka, Sebastian Thilemann, Joachim Fladt, Valerian L. Altersberger, Annaelle Zietz, Tolga D. Dittrich, Urs Fisch, Henrik Gensicke, Gian Marco De Marchis, Leo H. Bonati, Philippe A. Lyrer, Stefan T. Engelter, Nils Peters

Summary: In this observational study on AF-stroke patients treated with OAC, the presence of CMBs was associated with unfavorable clinical outcomes for both VKAs and DOACs, with a higher risk for recurrent IS than for ICH. Strokes were numerically higher under VKAs and increased in the presence of CMBs.

FRONTIERS IN NEUROLOGY (2022)

Article Clinical Neurology

Global Cortical Atrophy Is Associated with an Unfavorable Outcome in Stroke Patients on Oral Anticoagulation

Marta Kubacka, Annaelle Zietz, Sabine Schaedelin, Alexandros A. Polymeris, Lisa Hert, Johanna Lieb, Benjamin Wagner, David Seiffge, Christopher Traenka, Valerian L. Altersberger, Tolga Dittrich, Joachim Fladt, Urs Fisch, Sebastian Thilemann, Gian Marco De Marchis, Henrik Gensicke, Leo H. Bonati, Philippe Lyrer, Stefan T. Engelter, Nils Peters

Summary: Global cortical atrophy (GCA) is associated with the clinical prognosis of stroke patients with atrial fibrillation (AF) receiving oral anticoagulation.

CEREBROVASCULAR DISEASES (2023)

Article Clinical Neurology

Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients

Tolga D. Dittrich, Peter B. Sporns, Lilian F. Kriemler, Salome Rudin, Anh Nguyen, Annaelle Zietz, Alexandros A. Polymeris, Christopher Traenka, Sebastian Thilemann, Benjamin Wagner, Valerian L. Altersberger, Ines Piot, Filip Barinka, Martin Haensel, Henrik Gensicke, Stefan T. Engelter, Philippe A. Lyrer, Raoul Sutter, Christian H. Nickel, Mira Katan, Nils Peters, Lars Michels, Zsolt Kulcsar, Grzegorz M. Karwacki, Marco Pileggi, Carlo Cereda, Susanne Wegener, Leo H. Bonati, Urs Fischer, Marios Psychogios, Gian Marco De Marchis

Summary: This study examined the safety and efficacy outcomes of mechanical thrombectomy (MT) in patients with anterior circulation large vessel occlusions (LVO) who fulfilled or did not fulfill the DEFUSE-3 and DAWN trial inclusion criteria. The results showed that there were no significant differences in outcomes between patients who fulfilled the criteria and those who did not, suggesting the need for randomized trials with broader inclusion criteria for MT.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Clinical Neurology

Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study

Tolga D. Dittrich, Peter B. Sporns, Lilian F. Kriemler, Salome Rudin, Anh Nguyen, Annaelle Zietz, Alexandros A. Polymeris, Christopher Tranka, Sebastian Thilemann, Benjamin Wagner, Valerian L. Altersberger, Ines Piot, Filip Barinka, Susanne Mueller, Martin Haensel, Henrik Gensicke, Stefan T. Engelter, Philippe A. Lyrer, Raoul Sutter, Christian H. Nickel, Mira Katan, Nils Peters, Zsolt Kulcsar, Grzegorz M. Karwacki, Marco Pileggi, Carlo Cereda, Susanne Wegener, Leo H. Bonati, Urs Fischer, Marios Psychogios, Gian Marco De Marchis

Summary: This study evaluated the efficacy and safety of mechanical thrombectomy (MT) in adult stroke patients with anterior circulation large vessel occlusion presenting in the late time window not fulfilling the DEFUSE-3 and DAWN inclusion criteria. The study found that MT was associated with higher odds of favorable functional outcomes without an increased risk of symptomatic intracranial hemorrhage. These findings support the use of more permissive inclusion criteria for MT in the late time window.

STROKE (2023)

Article Clinical Neurology

Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications - the PLEURA study

Tolga D. Dittrich, Mara Aujesky, Salome Rudin, Annaelle Zietz, Benjamin Wagner, Alexandros Polymeris, Valerian L. Altersberger, Tim Sinnecker, Henrik Gensicke, Stefan T. Engelter, Philippe Lyrer, Viviane Hess, Raoul Sutter, Christian H. Nickel, Leo H. Bonati, Urs Fischer, Marios Psychogios, Mira Katan, Gian Marco De Marchis

Summary: This study retrospectively included data from 2715 patients with acute stroke and found that 5.9% (161/2715) of patients had pulmonary lesions on CTA. Approximately one-third of these lesions (58/161) were suspicious for malignancy. Further investigation confirmed primary or secondary pulmonary malignancy in two-thirds of patients (12/16) and they received oncologic therapy.

EUROPEAN STROKE JOURNAL (2023)

No Data Available